Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jinlong Yu

Showing results (121-130 of 123) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 123 results.
Bioactive Materials|March 18, 2026
Dual-engineering metalloimmunotherapy mediates <i>Staphylococcus aureus</i> virulence silencing and biofilm immune microenvironment reprogramming against implant-associated infectionsFeng Jiang, Qize Xuan, Yujie Hu, et al.
Molecular Neurobiology|March 30, 2016
Genetic Variants of Microtubule Actin Cross-linking Factor 1 (MACF1) Confer Risk for Parkinson's DiseaseXin Wang, Nuomin Li, Nian Xiong, et al.
Cancer Letters|April 3, 2016
Epigenetic silencing of miR-490-3p promotes development of an aggressive colorectal cancer phenotype through activation of the Wnt/β-catenin signaling pathwayKehong Zheng, Xinying Zhou, Jinlong Yu, et al.
Pageof 13

Showing results (121-130 of 123) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 123 results.
Bioactive Materials|March 18, 2026
Dual-engineering metalloimmunotherapy mediates <i>Staphylococcus aureus</i> virulence silencing and biofilm immune microenvironment reprogramming against implant-associated infectionsFeng Jiang, Qize Xuan, Yujie Hu, et al.
Molecular Neurobiology|March 30, 2016
Genetic Variants of Microtubule Actin Cross-linking Factor 1 (MACF1) Confer Risk for Parkinson's DiseaseXin Wang, Nuomin Li, Nian Xiong, et al.
Cancer Letters|April 3, 2016
Epigenetic silencing of miR-490-3p promotes development of an aggressive colorectal cancer phenotype through activation of the Wnt/β-catenin signaling pathwayKehong Zheng, Xinying Zhou, Jinlong Yu, et al.
Pageof 13